Illumina, Inc. (NASDAQ: ILMN) today announced the release of its novel 5-base solution, enabling researchers to pursue ...
The Genomics Core offers a wide range of DNA library preps from whole-genome PCR free to amplicon sequencing and CRISPR-Cas 9 validation. We also work with users to complete ChIP-seq and CUT&RUN ...
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map ...
Whole genomic sequence technique can detect exceptional DNA features of breast cancer cells that help precision cancer therapy for over 15000 women a year.
Illumina (ILMN) announced the release of its novel 5-base solution, enabling researchers to pursue broader biological questions with accuracy and ...
Michigan Tech's Genomic Sequencing Lab, part of the University's Health Research Institute, plays a leading role in tracking ...
More than 15,000 breast cancer patients could benefit from whole genome sequencing each year, according to scientists at the ...
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...